01.04.2021 Eloxx Pharmaceuticals Acquires Zikani Therapeutics

Press Release
24.03.2021Aura Biosciences Expands Executive Leadership Team with the Appointment of Mark De Rosch, Ph.D., as Chief Operating Officer

Press Release
22.03.2021Aura Biosciences Announces Oversubscribed $80 Million Financing

Press Release
17.03.2021Advent Life Sciences’ founded Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Press Release
17.03.2021Amphista Therapeutics raises $53M in oversubscribed Series B round to advance next generation targeted protein degradation assets

Press Release
12.03.2021Advent Life Sciences Becomes Latest Partner of One Nucleus

Press Release
02.03.2021Highlight Therapeutics and Pivotal work together on Melanoma therapy and launch a Phase IIa trial to examine BO-112 efficacy and safety

Press Release
18.02.2021 Advent Life Sciences Announces Close of Two New Funds Totalling $215 million

Press Release
16.02.2021Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model

Press Release
25.01.2021Iterum Therapeutics Announces U.S. FDA Filing Acceptance of New Drug Application for Oral Sulopenem

Press Release